Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.52 USD | +2.23% | -6.23% | -28.39% |
Apr. 02 | EyePoint Pharmaceuticals, Inc. Expands Scientific Advisory Board | CI |
Mar. 18 | EyePoint Pharmaceuticals, Inc.(NasdaqGM:EYPT) added to S&P Pharmaceuticals Select Industry Index | CI |
Financials (USD)
Sales 2024 * | 47.06M | Sales 2025 * | 17.36M | Capitalization | 805M |
---|---|---|---|---|---|
Net income 2024 * | -79M | Net income 2025 * | -144M | EV / Sales 2024 * | 12.5 x |
Net cash position 2024 * | 215M | Net cash position 2025 * | 348M | EV / Sales 2025 * | 26.3 x |
P/E ratio 2024 * |
-10.5
x | P/E ratio 2025 * |
-6.19
x | Employees | 121 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.79% |
Latest transcript on EyePoint Pharmaceuticals, Inc.
1 day | -1.88% | ||
1 week | -7.66% | ||
Current month | -21.82% | ||
1 month | -25.50% | ||
3 months | -35.10% | ||
6 months | +154.89% | ||
Current year | -30.07% |
Managers | Title | Age | Since |
---|---|---|---|
Jay Duker
CEO | Chief Executive Officer | 66 | 16-09-26 |
George Elston
DFI | Director of Finance/CFO | 59 | 19-11-13 |
Said Saim
CTO | Chief Tech/Sci/R&D Officer | 66 | 19-06-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Duker
CEO | Chief Executive Officer | 66 | 16-09-26 |
Wendy DiCicco
BRD | Director/Board Member | 56 | 19-07-14 |
David Guyer
BRD | Director/Board Member | 64 | 19-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.84% | 11 M€ | -6.03% | - | |
0.37% | 4 M€ | -5.15% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 16.58 | +2.63% | 298 235 |
24-04-25 | 16.16 | -1.88% | 749,630 |
24-04-24 | 16.47 | -6.26% | 1,178,938 |
24-04-23 | 17.57 | +3.66% | 942,987 |
24-04-22 | 16.95 | -3.97% | 1,386,877 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.07% | 805M | |
+24.17% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.45% | 233B | |
+6.04% | 201B | |
-10.51% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- EYPT Stock